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The homeodomain transcription factors play crucial roles inmany developmental processes ranging from organization of the body plan to
differentiation of individual tissues. The homeodomain protein Distal-less-3 (DLX3) has an essential role in epidermal stratiﬁcation and
development of ectodermal appendages, placenta and bones. A four-nucleotide deletion in the human DLX3 gene is etiologic for the
human hereditary tricho-dento-osseous (TDO) ectodermal dysplasia, a dominant syndrome characterized by abnormalities in hair, nails,
teeth, and bones.Wehave previously demonstrated thatDLX3 gene expression induces degradation ofDNp63a, a speciﬁc product of the
TP63 gene, a master regulator of multi-layered epithelia. Here we show that theDLX3TDOmutant protein is unable to promoteDNp63a
protein degradation and impairs the expression of cell cycle regulatory proteins and skin differentiationmarkers. However, we found that
in cell expressing equal amounts of mutant and wild-type DLX3, DNp63a protein level is efﬁciently regulated implying that genetic
heterozygosity at the DLX3 locus protects TDO patients from developing severe p63-associated skin defects.
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Homeodomain transcription factors play crucial roles in many
developmental processes ranging fromorganization of the body
plan to differentiation of individual tissues (Merlo et al., 2000;
Morasso and Radoja, 2005). Distal-less-3 (DLX3) is a member
of the Dlx vertebrate family of homeodomain transcription
factors that comprises six members (Dlx1-6). The human
DLX3 gene maps to 17q21.33. It has an essential role in
development of the epidermis and ectodermal appendages such
as glands, teeth, and hair follicles, all structures involving
epithelial–mesenchymal interaction (Hassan et al., 2004;Hwang
et al., 2008). DLX3 is broadly expressed in early embryonic
ectoderm, as well as in the limb bud and mammary gland and
homozygous deletion of the mouse Dlx3 gene results in
placental failure leading to embryonic death between days 9.5
and 10 (Morasso et al., 1999).
In skin, DLX3 expression is restricted to the suprabasal
layers of epidermis where it is implicated in regulating
transcription of late differentiationmarkers, such as loricrin and
proﬁlaggrin. Transgenic expression of Dlx3, in the basal
keratinocytes of mice, causes highly abnormal skin with a
pronounced reduction in thickness (Morasso et al., 1996).
Conversely, Dlx3 conditional knock-out, in epidermis, resulted
in epidermal hyperplasia, thickened epidermis, and abnormal
hair development (Hwang et al., 2008).
The most common DLX3 gene mutation
(c.571_574delGGGG), just downstream of the DLX3
homeodomain, is etiologic for tricho-dento-osseous syndrome
(TDO; MIM# 190320). TDO is an autosomal-dominant genetic
disorder characterized by kinky hair, brittle nails, enamel
hypoplasia, taurodontism, and mild to moderate increased
bone density (Price et al., 1998). All these traits are highly
penetrant yet clinically variable components of TDO (Price
et al., 1998). Recently, another DLX3 gene mutation
(c.561_562delCT), inside the DLX3 homeodomain, was
reported to be associated with an attenuated TDO phenotype
(Wright et al., 2008) or with Amelogenesis Imperfecta with
Taurodontism (AIHHT) (Lee et al., 2008).
The c.571_574delGGGG deletion causing TDO syndrome
results in a frameshift after the ﬁrst codon following the
homeodomain and thus exhibits an aminoacid sequence that
differs from the C-terminal domain in wild-type DLX3. The
frameshift also results in the truncation of the protein to 255
amino acids insteadof 287 (Duverger et al., 2008). Themutation
does not alter the structure of the homeobox domain, the NLS
region or the nuclear localization of the protein (Choi et al.,
2008; Duverger et al., 2008). The dominant pattern of
inheritance may be due to the formation of non-functional
complexes involving the truncated DLX3 that acts either
through a dominant-negative or a gain of function mechanism
(Duverger et al., 2008).
Concerning the transcriptional ability of DLX3TDO alone, it
was shown to gain transcriptional activity on the osteocalcin
gene promoter (Choi et al., 2008) while it was found defective
on the Runx2 promoter (Duverger et al., 2008). Furthermore,
when DLX3WT and DLX3TDO were co-expressed they formed
a complex that could bind DNA and DLX3TDO exerted a
dominant negative effect on DLX3WT transcriptional activity
(Duverger et al., 2008).
The DLX3 gene promoter is induced by TAp63a, a speciﬁc
product of the p63 gene (Radoja et al., 2007). The p63 gene is a
master regulatory gene of multi-layered epithelia (Pozzi et al.,
2009). P63 null mice show cranial and limb malformations; they
also lack stratiﬁed skin and all epithelial derivatives (Mills et al.,
1999). p63 belongs to the p53 family of transcription factors
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and is expressed as multiple protein isoforms that are classiﬁed
into two groups designated TA andDNp63. Alternative splicing
at the 30 end generates TA and DNp63 proteins with different
C-termini, denoted a, b, and g (Yang et al., 1998). In stratiﬁed
skin, DNp63a expression, which supports the proliferative
potential of keratinocytes, decreases progressively from the
basal to the suprabasal, more differentiated, layers of the
epidermis, where TAp63 isoforms appear to be expressed
(King et al., 2006). Interestingly, unlike TAp63a, DNp63a does
not induce DLX3 gene transcription (Lo Iacono et al., 2008).
Mutations of p63 were found to be responsible for several
distinct human hereditary syndromes, some associated with
ectodermal dysplasia including the split-hand and foot
malformation IV (SHFM IV), the ectrodactily ectodermal
dysplasia clefting (EEC) and the ankyloblepharon-ectodermal
defects-cleft lip/palate (AEC) (Brunner et al., 2002). Recently,
we have demonstrated that mutant p63 proteins derived from
AEC patients exhibit an impaired ability to transactivate the
DLX3 gene promoter thus showing that DLX3 and p63 are
involved in a common pathway which is relevant for
development of skin, hair, teeth, and other epidermal
derivatives (Radoja et al., 2007). Moreover, we have shown that
DLX3 triggers proteasome-mediated degradation of DNp63a
through a Raf 1 kinase-dependent pathway (Di Costanzo
et al., 2009).
In this workwe explore the effect of themost commonTDO
mutation on the ability of DLX3 to regulate the DNp63a
protein level.
Materials and Methods
Plasmids and reagents
Expression plasmids for V5 or FLAG tagged wild-type (DLX3WT)
and mutant DLX3 (DLX3TDO) have been previously described
(Duverger et al., 2008).
Cell culture and transfection
Normal human foreskin keratinocytes (HK) were isolated and
cultured according to Bitoun et al. (2003). HaCaT and H1299 cells
were maintained as already described (Di Costanzo et al., 2009).
HK were transiently transfected with increasing amount (2 and
3mg) of pCI-Neo-DLX3 or pCI-Neo-TDO expression vector
using Neon-Transfection system (Invitrogen, Life Technologies.
Inc., Milan, Italy), according to manufacturer’s instructions.
HaCaT keratinocytes were grown until 80% conﬂuence
(corresponding to day 0¼ t0), then differentiation was induced for
up to 5 days in DMEM w/o serum containing 2mM calcium.
HaCaT cells were transiently transfected with increasing
amount (3 and 4mg) of pCI-Neo-V5-DLX3 or pCI-Neo-TDO
expression vector using LipofectAMINE 2000 reagent (Invitrogen,
Life Technologies. Inc.). When necessary, the total amount of
transfected DNA was kept constant using an empty expression
vector. At 24 h post-transfection, cells were lysed and total protein
quantiﬁed with the BioRad protein assay. Twenty micrograms of
extracts was resolved by sodium dodecyl sulfate (SDS)–PAGE. To
detect Raf1 and TDO interaction in HaCaT cells, 1.0 106 cells
were plated in 100mm dishes and transfected with 4mg of pCI-
Neo-DLX3 or pCI-Neo-TDO expression vector. To detect
interaction between TDOandDLX3, 1.0 106 cells were plated in
100mmdishes and transiently transfectedwith equal amount (5mg
for plate) of pCI-Neo-TDO or pcDNA 3.1 FLAG-DLX3 alone or
pCI-Neo-TDO and pcDNA 3.1 FLAG-DLX3 in a 1–1 ratio (2.5mg
of DLX3 and 2.5mg of TDO expression plasmid). To generate
HaCaT stable clones expressing DLX3TDO, 7 105 cells were
plated in 100mmdishes and transfected with 5mg of empty vector,
pCI-Neo-V5-DLX3 or pCI-Neo-V5-TDO plasmid. Twenty-four
hours after transfection, each 100mm plate was split (1:20) and
cells were selected by adding G418 (100mg/ml) to the cell culture
medium. After 3weeks, HaCaT stable cloneswere established only
from DLX3TDO transfected cells. Isolated clones were picked up
and expanded, and their DLX3TDO gene expression was
determined by western blot and speciﬁc immunodetection using
antibodies against the V5 epitope. The #HC3TDO stable clone
(1.0 106 cells) was transiently transfected, in 100mmdishes, with
5mg of pcDNA3-FLAG-DLX3 using Neon-Transfection system
(Invitrogen, Life Technologies, Inc.). Extracts were prepared and
subjected to co-immunoprecipitation.
Western blot analysis and co-immunoprecipitation
At 24 h after transfection cells were lysed in 10mM Tris–HCl (pH
7.5), 1mM EDTA, 150mMNaCl, 0.5%NP-40, 1mM dithiothreitol,
1mM phenylmethylsulfonyl ﬂuoride, 0.5% sodium deoxycholate,
and protease inhibitors. Cell lysates were incubated on ice for
30min and the extracts were centrifuged at 13,000 rpm for 10min
to remove cell debris. Protein concentrations were determined by
the BioRad protein assay. After the addition of 2 loading buffer
(2% SDS, 30% glycerol, 300mMb-mercaptoethanol, 100mMTris–
HCl pH 6.8), the samples were incubated at 958C for 5min and
resolved by SDS–PAGE. Proteins were transferred to a PVDF
(Millipore, Mila, Italy) and probed with the appropriate antibodies.
For immunoprecipitation in HaCaT keratinocytes, 1.0 106 cells
were seeded in 100mm dishes and transfected with plasmids as
indicated (see legend to ﬁgure). Cells were harvested 24 h post-
transfection and cell lysates were prepared as described above.
Onemicrogram of whole cell extracts was preclearedwith 30ml of
protein A-agarose (50% slurry; Roche, Manheim, Germany) and
then incubated overnight at 48Cwith the following antibodies: 3mg
of anti-V5 (AbD Serotec, Oxford, UK), 3mg anti-Flag (M2 clone,
Sigma-Aldrich, Germany). Immunocomplexes were collected by
incubation with 30ml of protein A-agarose (Roche) at 48C for 4 h.
The beads were washed with Co-IP buffer (50mM Tris–HCl pH
7.5; 150mM NaCl; 5mM EDTA; 0.5% NP-40; 10% glycerol),
resuspended in 2 loading buffer (Sigma) and loaded into an SDS–
10% polyacrylamide gel. Proteins were then transferred onto a
PVDFmembrane (Millipore) and probedwith the indicated primary
antibodies. Proteins were visualized with an enhanced
chemiluminescence detection system (Amersham). Images were
taken with CHEMIDOC (Biorad) and analyzed with the
QuantityONE software.
Antibodies
p63 (4A4), actin (I-19), citokeratin 1 (4D12B3), citokeratin 10 (VIK-
10) sc-51581, anti-14-3-3s (stratiﬁn) sc-7681, anti-Raf1 (C-12) sc-
133, anti-DLX3 (C-20) sc-18143, and anti-p21WAF (C19) sc-397
were from Santa Cruz, Biotechnologies Inc., Germany. Anti-FLAG
(M2 clone) from Sigma; anti-V5 (AbD Serotec); anti-cyclin D1
(2922), Phospho-c-Raf (Ser338) (56A6), Phospho-Akt (Ser473)
(9271S), and Phospho-c-Raf (Ser259) (9421S) were from Cell
Signaling Technology, Denver.
Luciferase assay
For luciferase assays, 200 ng of reporter DNA (DNp63-3Kb
promoter or p21/WAF1 promoter luciferase construct) and
different amounts of each of the indicated effectors (see legend to
ﬁgure) were transfected along with 40 ng of pRL (Renilla
Luciferase) as internal transfection control (Dual Reporter
Luciferase Assay, Promega, Milan, Italy). Cells were lysed after 24 h
and luciferase activity determined.
l-Phosphatase (l-PPase) treatment and immunoblotting
Total cell lysates prepared as duplicate samples were incubated
with or without 4U of l-phosphatase (New England Biolabs,
Frankfurt, Germany) for 1 h at 308C as suggested by the
manufacturer. Extracts were analyzed by SDS–PAGE using a high
resolving 8% gel (37.5:1 acryl/bis acrylamide).
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PCR analyses
HaCaT cells were transfected with DLX3WT or DLX3TDO
constructs (0.5, 1, and 1.5mg). For PCR analysis total RNA from
HaCaT cells was isolated using the RNA Mini Extraction Kit
(QiagenGmbH,Hilden,Germany) according to themanufacturer’s
instructions. Total RNA (1mg) was used to generate reverse
transcribed cDNA using SuperScript III (Invitrogen, Life
Technologies, Inc.). Real Time PCRwas performedwith a 7500RT-
PCR Thermo Cycler (Applied Biosystem, Monza, Italy) using SYBR
GREENMaster Mix (Applied Biosystem). All samples were done in
triplicate. Human hypoxanthine phosphoribosyl transferase
(HPRT) was used for normalization. The results were expressed
with the value relative to HPRT (set at 1) for each mRNA sample.
For DNp63a and p21WAF expression, the following
oligonucleotides were used:
DNp63a (sense) 50CCA CAG TAC ACG AAC CTG GGG
DNp63a (antisense) 50CCG GGT AAT CTG TGT TGG AG
p21WAF (sense) 50AAGACCATGTGGACCTGTCA
p21WAF (antisense) 50GGCTTCCTCTTGGAGAAGAT
HPRT gene was ampliﬁed using the following primers:
(F) 50 CCT GCT GGA TTA CAT TAA AGC
(R) 50 CTT CGT GGG GTC CTT TTC
The ampliﬁcation sequence consisted of 30 cycles of 948C/10,
558C/10, 728C/10. PCR products were resolved by 2% agarose
electrophoresis. RT-PCR ampliﬁcation results were analyzed by
Quantity One software (Biorad).
Results
DLX3TDO is unable to induce DNp63a degradation
We have previously shown that DLX3 expression induces
degradation of DNp63a protein, in human and mouse
keratinocytes (Di Costanzo et al., 2009). Since TDO patients
exhibit ectodermal dysplasia characterized by hair, nail, and
tooth defects, we explored the possibility that the TDO
mutation could, in some way, affect the ability of DLX3 to
down-regulate DNp63a protein levels. To address this
question, we compared the effect of enforced expression of
wild-type (DLX3WT) or mutant DLX3 (DLX3TDO) onDNp63a
protein level, in human keratinocytes. Brieﬂy, we transfected
both human embryonic (NHEK) and spontaneously
immortalized (HaCaT) keratinocytes either with DLX3WT or
DLX3TDO expression plasmids and evaluated the level of
endogenous DNp63a by immunoblot. In agreement with our
previous ﬁndings (Di Costanzo et al., 2009), DLX3WT efﬁciently
reduced DNp63a protein level. Conversely, the expression
level of DNp63a was unaffected by DLX3TDO (Fig. 1A,B).
Therefore, we examined the possibility that DLX3TDO protein
might enhance DNp63a gene transcription thus resulting in
higher levels of DNp63a in cells expressing DLX3TDO,
compared to those expressing thewild-type protein. The ability
of DLX3TDO to transactivate DNp63a gene transcription was
ﬁrst analyzed by reporter assays. The DNp63a promoter-
luciferase construct was co-transfectedwith increasing amount
Fig. 1. DLX3TDOmutantwasunableto induceDNp63adegradation.NHEK(A)orspontaneously immortalized(HaCaT)keratinocytes (B)were
transiently transfectedwith an empty vector or increasing amount (3 and 4mg) of pCI-V5-DLX3or pCI-V5-TDOencoding plasmids. At 24 h after
transfection cellswere lysed and20mgprotein extractswere fractionatedbySDS–PAGEandanalyzedbyWesternblot.DNp63aexpression level
wasrevealedbyimmunoblotwithantibodiesdirectedagainstp63(4A4)whileV5-DLX3WTandV5-DLX3TDOexpressionlevelswereevaluatedwith
antibodies against theV5tag.Actinwasusedas loadingcontrol. ImageswereacquiredwithCHEMIDOC(Biorad) andanalyzedwith theQuantity-
ONEsoftware.C:H1299cellswere transiently transfectedwithDNp63apromoter luciferase-construct aloneorwith increasing amount (0.3, 0.6,
0.8, 1mg) ofDLX3WTorDLX3TDOexpressionplasmids. Luciferase activitywas assayed24 hafter transfection. Eachhistogrambar represents the
meanof at least three independentbiological replicates afternormalization toRenilla luciferase activity to correct for transfectionefﬁciency.The
activity of the sample transfectedwith the reporter alonewas set toone.D:QuantitativeRT-PCRexpressionanalysis of endogenousDNp63awas
performedon totalRNAfromHaCaTkeratinocytes transiently transfectedwith increasingamounts (from0.5 to1.5mg)ofDLX3WTorDLX3TDO
encoding vectors.Thehistogramshows the fold changeof expression levels inexperimental samples relative to samples transfectedwith1.5mgof
empty plasmid. Each histogrambar represents themeanof three biological replicateswhile error bars show the standard deviation ofDCTvalues
obtained for three replicates of each sample type.
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of DLX3WT or DLX3TDO expression plasmid into the p53/p63-
null H1299 cell line, to avoid interference by endogenous p53 or
p63. As shown in Figure 1C, the luciferase activity of the
DNp63a-luciferase construct was not signiﬁcantly increased in
the presence of DLX3WT or DLX3TDO when compared to the
baseline in absenceof proteins.QRT-PCR assays, performedon
total RNA from mock, DLX3WT or DLX3TDO-transfected
HaCaT keratinocytes, conﬁrmed that DLX3TDO expression
does not increase the abundance of DNp63a transcript
(Fig. 1D).
It is well known that primary proliferating keratinocytes
exhibit high levels of DNp63a which is down-regulated during
differentiation (Parsa et al., 1999; Bamberger et al., 2002) while
the upregulation of the cyclin-dependent kinase inhibitor
(CDKI) p21WAF is required for initial commitment of
keratinocytes to differentiate (Wong et al., 2010).
Accordingly, in differentiating HaCaT keratinocytes, we
observed down-regulation of DNp63a in parallel with the
enhancement of p21WAFandDLX3expression levels (Fig. 2A).
Since DNp63a was shown to bind to the p21WAF1 gene
promoter resulting in transcriptional repression (Westfall et al.,
2003), we reasoned that down-regulation of DNp63a induced
by DLX3, would cause de-repression of p21WAF gene
transcription. According to this notion, enforced expression of
DLX3, in HaCaT cells, resulted in an increase of the p21WAF
protein level, as assessed by western blot assay (Fig. 2B).
Unexpectedly, we observed a similar increase of p21WAF
following DLX3TDO enforced expression but without
reduction of DNp63a abundance (Fig. 2B). Therefore, we
transiently transfected DLX3WT or DLX3TDO expression
vectors intoH1299 cells along with a PGL3 plasmid carrying the
human p21WAF promoter. Luciferase assays showed that
mutant DLX3TDO gained the ability to induce the p21/WAF
promoter (Fig. 2C). Next, we performed Real-Time PCR on
total RNA from HaCaT keratinocytes. As shown in Figure 2D,
we found an increase of p21WAF speciﬁc transcript both in
DLX3WT and DLX3TDO transfected cells.
It was reported that differentiation of human keratinocytes is
impaired by expression of DNp63a (Parsa et al., 1999;
Bamberger et al., 2002). Therefore, we analyzed the expression
of p21/WAF and speciﬁc skin differentiation markers, such as
CK1, CK10, and stratiﬁn (14-3-3s by immunoblot in HaCaT
keratinocytes transfected with DLX3WT or DLX3TDO
expression vectors). As shown in Figure 3A, DLX3WT enforced
expression caused induction of 14-3-s tratiﬁn, p21/WAF, and
the suprabasal keratinsCK1 andCK10, alongwith the expected
reduction ofDNp63a. Interestingly, DLX3TDO expressing cells
showed induction of p21/WAF while stratiﬁn, CK1, CK10 as
Fig. 2. p21-WAF1 up-regulation in HaCaT cells expressing DLX3WT or DLX3TDO proteins (A). HaCaT cells were induced to differentiate with
2mMCa2Randextractswere subjected to immunoblotwith anti-p63 (4A4),DLX3, andp21WAFantibodies.Actinwasusedas loading control. B:
HaCaT cellswere transfectedwith increasing amount (3 and 4mg) ofDLX3WTorDLX3TDOplasmids. Twenty-four hours after transfection 20mg
protein extracts were subjected to immunoblot and revealed with antibodies against p63, p21WAF1, and the V5 tag. Actin was used as loading
control.C:H1299cellsweretransfectedwithpGL3-p21WAF1promoteralone,witha1mgofpcDNA3-p53plasmidaspositivecontrolor increasing
amount (0.5 and 1mg) of DLX3WT or DLX3TDO expression plasmids. Luciferase activity was assayed 24 h after transfection. Each histogram bar
represents the mean of at least three independent transfections after normalization to Renilla luciferase activity. D: Quantitative RT-PCR
expression analysis of endogenous p21WAF was performed on total RNA from HaCaT keratinocytes transiently transfected with increasing
amounts (from0.5 to1.5mg)ofDLX3WTorDLX3TDOencodingvectors.Thehistogramshows the fold changeofexpression levels inexperimental
samplesrelativetosamplestransfectedwith1.5mgofemptyplasmid(mock).Eachhistogrambarrepresentsthemeanofthreebiologicalreplicates
while error bars show the standard deviation of DCT values obtained for three replicates of each sample type.
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well as DNp63a protein levels were almost undistinguishable
from those observed in mock transfected cells thus suggesting
that DLX3TDO expression impairs the expression of skin
differentiation markers (Fig. 3A).
It was previously demonstrated that during differentiation of
HaCaT keratinocytes, persistence/enforced expression of
cyclin D1, rather than p21WAF up-regulation, inhibits the
expression of skin differentiation markers and that down-
regulation of cyclin D1 is crucial for permanent cell cycle exit
and keratinocyte terminal differentiation (Nishi et al., 2009).
Therefore, we monitored the expression levels of cyclin D1, in
total extracts from DLX3WT or DLX3TDO transfected cells.
Remarkably, DLX3WT, but not DLX3TDO, caused a dramatic
reduction of cyclin D1 (Fig. 3B).
DLX3TDO is unable to interact and induce Raf1
phosphorylation at Ser338
We have previously shown that DLX3 interacts with Raf1 and
causes enhancement of Raf1 phosphorylation at Ser338. Both
events were found to be necessary for phosphorylation-
dependent DNp63a degradation induced by DLX3 (Di
Costanzo et al., 2009). We analyzed whether impaired
degradation of DNp63a following mutant DLX3TDO
expression, could be ascribed to the inability of the DLX3TDO
protein to interact with Raf1 and/or promote Raf1
phosphorylation. To address this point, we transfected
DLX3TDO in HaCaT cells to examine the phosphorylation
status of Raf1 with two different phospho-speciﬁc Raf1
antibodies. The ﬁrst antibody was directed against phospho-
Ser338 (pSer338) which is the target of Raf1 self-phosphorylation
in response to mitogens (Zang et al., 2008), while the latter was
against phospho-Ser259 (pSer259), a phosphoacceptor site
speciﬁcally targeted by Akt kinase activation (Diaz et al., 1997).
As expected, transient expression of DLX3WT, in HaCaT cells,
increased the phosphorylation status of Raf1 at Ser338 while
mutant DLX3TDO seemed even to reduce Raf1
phosphorylation (Fig. 4A). Neither DLX3WT nor DLX3TDO
signiﬁcantly affected the phosphorylation status of Akt kinase
and Raf1 at Ser259 (Fig. 4A). We also examined if Raf1
expression was modulated by wild-type or mutant DLX3 at the
transcription level by Real Time PCR and found no signiﬁcant
differences (Fig. 4B). Next, we hypothesized that impaired
phosphorylation of Raf1 at Ser338 was due to the inability of
DLX3TDO homodimers to interact with and activate Raf1
kinase autophosphorylation. To address this point we
transiently expressed, in HaCaT cells, DLX3WT or DLX3TDO,
as V5-Tag fusion proteins and immunoprecipitated them using
antibodies against the V5 epitope. As expected endogenous
Raf1 was efﬁciently co-immunoprecipitated in cells expressing
V5-DLX3WT, while in cells expressing V5-DLX3TDO it was
barely detectable, thus suggesting that the TDO mutation
impaired the ability of DLX3 to interact with Raf1 (Fig. 4C).
Moreover, on conventional SDS–PAGE, DLX3WT but not
DLX3TDOhad a smeared appearance (see Fig. 1A,B). To check if
this was due toDLX3 protein phosphorylationwe employed l-
phosphatase assay on extracts from HaCaT cells expressing
DLX3WT or DLX3TDO. The extracts were then analyzed by
high-deﬁnition SDS–PAGE and speciﬁc immunoblot (see
Materials and Methods Section). Following this treatment the
electrophoretic band corresponding to DLX3WT showed a
different electrophoretic mobility and appeared unique and
sharp, similar to that of DLX3TDO which was completely
unaffected by l-phosphatase treatment (Fig. 4D). This
observation suggests that, in human keratinocytes, DLX3WT,
but not DLX3TDO, is a phosphoprotein.
DLX3WT/DLX3TDO heterodimers are able to interact
with Raf1 and promote p63 degradation
Although DLX3TDO protein is defective in controlling the level
ofDNp63a protein in keratinocytes, TDOpatients rarely show
overt skin abnormalities (Hart et al., 1997). We wanted to
mimic the in vivo situation of TDOpatients expressing both the
wild-type andmutant protein. Since it was already reported that
DLX3WT and DLX3TDO, when co-expressed, are able to form
heterodimeric complexes that can bind DNA (Duverger et al.,
2008) we checked for presence of DLX3WT/DLX3TDO
heterodimers in HaCaT cell lysates transfected with both
proteins. Brieﬂy, HaCaT keratinocytes were transfected with
expression vectors for DLX3WT tagged with a Flag epitope and
DLX3TDO tagged with a V5 epitope. Protein complexes were
immunoprecipitated with anti-Flag antibodies to
immunoprecipitate DLX3 and analyzed for the presence of
DLX3TDO using antibodies against the V5 epitope. As shown in
Figure 5A, DLX3TDO protein was present in DLX3WT
immunocomplexes.
Next, we investigated whether DLX3WT/DLX3TDO
heterodimers were able to promote Raf1 phosphorylation and
DNp63a degradation. Therefore, we transfected equal amount
ofDLX3WT andDLX3TDOplasmids inHaCaT cells and checked
by immunoblot the level of DNp63a protein. As shown in
Figure 5B, co-expression of equivalent amounts of DLX3WT
and DLX3TDO protein, in HaCaT cells, resulted in efﬁcient
DNp63a degradation and enhancement of the phosphorylation
status of Raf1 at Ser338.
Then, we decided to generate stable clones, from HaCaT
cells, expressing both DLX3WT and DLX3TDO proteins. Stable
transfection of DLX3WT caused a massive cell death making it
impossible to isolate DLX3 expressing HaCaT clones. Instead,
we could easily isolate clones expressing the DLX3TDO mutant
protein (Fig. 6A). Remarkably, stable clones expressing
Fig. 3. DLX3TDO impairs the expression of skin differentiation
markers. A: HaCaT cells were trasfected with an empty plasmid
(mock) or with a ﬁxed amount (3mg) of DLX3WT or DLX3TDO
expression plasmids. Filters were probed with antibodies against p63
(4A4), V5, 14.3.3s, CK1, CK10, and p21WAF. Actin was used as
loading control. B: HaCaT cells were transiently transfected with an
empty vector (mock) or increasing amount (3 and 4mg) of DLX3WT
and DLX3TDO constructs. Twenty-four hours after transfection total
lysate (20mg) was immunoblotted with anti-cyclin D1 and anti-V5
antibodies. Actin was used as loading control.
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detectable levels of DLX3TDO exhibited higher levels of
DNp63a compared to the others showing no DLX3TDO
expression (Fig. 6A, compare lanes 3 and 4 with lanes 1 and 2).
The #HC3TDO clone, expressing a high level of DLX3TDO, was
selected for transient transfection with the expression vectors
for Flag tagged DLX3WT. At 48 h from transfection, total cell
lysates were prepared and the expression level ofDNp63a and
cyclin D1were analyzed by immunoblot. As shown in Figure 6B,
DNp63a abundance was greatly reduced while cyclin D1 was
upregulated, thus proving that DLX3WT and DLX3TDO co-
expression can rescue the negative control on DNp63a.
Furthermore, we performed co-immunoprecipitation assay in
HC3TDO cells, transiently transfected with the expression
vectors for Flag tagged DLX3WT and we found the presence of
DLX3TDO in Flag-immunoprecipitated complexes (Fig. 6C),
thus conﬁrming that DLX3WT and DLX3TDO form
heterodimers when co-expressed in keratinocytes.
Discussion
DLX3 and p63 act as part of a series of regulatory cascades that
ultimately lead to the formation of ectoderm-derived organs.
DLX3 and p63 gene mutations, in vivo, are very rare and are
associated to human ectodermal dysplasia syndromes with
variable clinical expression. Our previous studies proved a
functional relationship between p63 and DLX3, with DLX3
being induced by TAp63 (Radoja et al., 2007) and responsible
for DNp63a protein degradation (Di Costanzo et al., 2009).
These ﬁndings provided a possible mechanistic explanation of
how DLX3 can control epithelial differentiation. Here, we
report that a naturally occurring mutation in the DLX3 gene,
responsible for TDO syndrome affects the ability of DLX3 to
down-regulate DNp63a protein level (Fig. 1A,B), further
strengthening the notion that DLX3 and p63 belong to a
common regulatory pathway relevant for the pathogenesis of
ectodermal dysplasias. Remarkably, enforced expression of
wild-type DLX3, but not mutant DLX3TDO protein, in human
keratinocytes, was accompanied by induction of skin speciﬁc
differentiation markers, such as Keratin 1 (CK1), Keratin 10
(CK10), and stratiﬁn (14-3-3s) (Fig. 3A).
We have previously demonstrated that Raf1 kinase is a
crucial player in DLX3-mediated DNp63a protein degradation
(Di Costanzo et al., 2009). Apparently, the failure of DLX3TDO
to down-regulate DNp63a is due to the inability of DLX3
mutant protein to interact with and activate Raf1 kinase, as it
does the wild-type protein (Fig. 4A,C).
In vivo evidence shows that ectopic expression of DLX3
gene causes skin defects. In 1996, it was reported that ectopic
Fig. 4. DLX3TDO protein is unable to interact with Raf1 and/or promote Raf1 phosphorylation. A: HaCaTwere transiently transfected with an
emptyvector (mock)or increasingamount (3and4mg)ofDLX3WTorDLX3TDOexpressionplasmids.Proteinextractswere fractionatedbySDS–
PAGEandanalyzedbyWesternblotwithantip63,anti-V5,anti-pRAFS338,anti-pRAFS259,anti-RAF,andanti-pAKTantibodies.Actinwasusedas
loading control. B:HaCaT cells weremock transfected or transfectedwith 3 and 4mg ofDLX3WTorDLX3TDOexpression vector. Total RNAwas
prepared fromuntransfected,mock,DLX3WTorDLX3TDOtransfectedHaCaTcells at 24 hpost-transfection.QRTPCRwasperformedwithRaf1
andHPRTspeciﬁcoligonucleotidesasdescribedinMaterialsandMethodsSection.Theexperimentwasperformedtwiceandsamplesweredonein
triplicate.HPRTwasusedfornormalization.TheresultswereexpressedwiththevaluerelativetoHPRT(setat1)foreachmRNAsample.Standard
deviations are also shown. C:Western blot of HaCaT cells transiently transfected with 4mg of V5-DLX3WT and V5-DLX3TDO encoding plasmid.
Equal amounts of total protein extracts were subjected to immunoblot and revealed with antibodies against RAF1 and the V5 tag (left part).
Equal amounts of extract from mock, V5-DLX3WT or V5-DLX3TDO transfected cells were immunoprecipitated with anti-V5 antibody and the
immunocomplexes were blotted and probed with anti-V5 or anti-Raf1 antibodies (right part). D: HaCaT cells were transfected with different
amount(0.5or1mg)ofV5-DLX3WTorV5-DLX3TDOplasmidsas indicated.At24 hafter transfection10mgofcell lysatesweretreatedornotwithl
protein phosphatase (l-PPase), analyzed by high resolving SDS–PAGE (see Materials and methods Section) and blotted with antibody to V5.
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expression of the DLX3 gene, under the keratin K5 promoter,
in the basal layer of the skin of transgenic mice, resulted in a
pronounced reduction in skin thickness reﬂecting suppression
of basal cell proliferation. A general decrease in the number of
suprabasal layers and ectopic synthesis of ﬁlaggrin and loricrin in
lower strata of epidermis was also observed (Morasso et al.,
1996). Conversely, epidermal speciﬁc ablation of DLX3, in
conditional knock-out mice, resulted in complete alopecia and
hyperplastic epidermis with an increase in the number of
proliferative cells and thickening of the entire stratiﬁed
epithelium (Hwang et al., 2008). Taken together, these
observations indicate that DLX3 expression in basal cells
transforms them into more differentiated keratinocytes while
the lack of a DLX3-regulated differentiation signal leads to
hyperproliferative epidermis. Unfortunately, homozygous
DLX3knock-outmice are embryonic lethal, thus hampering the
possibility to examine the effects of a complete loss of DLX3 in
adult skin, while DLX3 heterozygous mice did not present any
abnormalities thereby eliminating haplo-insufﬁciency as a
probable cause of DLX3-associated ectodermal dysplasia
(Morasso et al., 1999; Yang et al., 1999).
Our data show that both DLX3WT and DLX3TDO enforced
expression up-regulated p21WAF (Figs. 3A and 5B). However,
unlike the wild-type protein, DLX3TDO was unable to down-
regulate cyclin D1 (Fig. 3B). This observation is particularly
relevant since it is known that, in anchorage deprived
keratinocytes, induced to differentiate with calcium, cyclin D1
downregulation more than p21WAF induction, is crucial for
permanent cell cycle exit and terminal differentiation (Nishi
et al., 2009). Remarkably, HaCaT cells expressing TDO
proliferate more than control cells and express higher level of
cyclin D1 (Fig. 3B and data not shown). Furthermore, we failed
to isolateHaCaT stable clones expressingDLX3 supporting the
hypothesis that wild-type DLX3, but not DLX3TDO, promotes
irreversible cell cycle exit. Remarkably, we found that, not only
DNp63a but also cyclin D1 downregulation was rescued in
stable clones expressing both wild-type and mutant DLX3TDO
(Fig. 6B).
Since it is known that p21WAF and 14.3.3s promoters are
repressed by DNp63a association (Westfall et al., 2003),
reduction of DNp63a level by DLX3, in HaCaT cells, was
expected to result in an increase of p21WAF expression.
Intriguingly, we found that DLX3TDO was able to induce
p21WAF, notwithstanding the presence of DNp63a
expression (Figs. 2B and 3A). We can postulate that (1) either
induction of p21WAF is completely independent fromDNp63a
or (2) DLX3TDO has gained transcriptional activity on the
p21WAF promoter. Comparison between wild-type and
mutant DLX3 activity on the p21WAF promoter by reporter
assays, in H1299 cells bearing no DNp63a, supports the last
hypothesis (Fig. 2C). Moreover, our phosphatase assay
indicated that, in cultured HaCaT keratinocytes DLX3WT, but
not DLX3TDO, is a phosphoprotein. It is known that DLX3 is a
target of protein kinase C (PKC), we may hypothesize that the
structure of the TDO protein might impair phosphorylation of
the protein (Park et al., 2001) by PKC.
The role of DNp63a in keratinocyte differentiation is still
controversial. For instance enforced expression of DNp63a in
primary murine keratinocytes was reported to counteract
growth arrest and block expression of maturation-speciﬁc
proteins keratin 10, loricrin, and ﬁlaggrin (King et al., 2003).
However, retinoic acid treated keratinocytes express early
differentiation markers in presence of sustained expression of
DNp63a (Bamberger et al., 2002). Furthermore, transgenic
mice overexpressing DNp63a under the control of the loricrin
promoter show unaltered differentiation of keratinocytes
(Liefer et al., 2000). All these ﬁndings suggest thatDNp63aplays
a role in skin homeostasis but argue against DNp63a down-
regulation being the driving force for differentiation. Abnormal
persistence of DNp63a allows keratinocytes to proceed
through the early step of differentiation preventing processes,
such as p53 or TAp73d-mediated transcription, that are speciﬁc
for terminal differentiation in suprabasal layers of the epidermis
(De Laurenzi et al., 2000).
Tricho-dento-osseous syndrome is a rare human genetic
disease. TDO patients express a wild-type and a dominant
DLX3TDOmutant allele. They do not usually show an overt skin
phenotype and only two clinical cases have been reported, so
far, describing TDO female patients with skin lesions
(Lichtenstein et al., 1972; Mayer et al., 2010). Herein, we
demonstrate that co-expression of wild-type and mutant
DLX3TDO results in the formation of DLX3WT/DLX3TDO
heterodimers (Figs. 5A and 6C) that are able to down-regulate
DNp63a protein level (Figs. 5B and 6B) and promote Raf1
kinase activation (Fig. 5B). Our observations suggest that co-
expression of the mutant and wild-type DLX3 allele should, at
least in part, protect TDO patients from developing p63-
associated skin abnormalities. At present, however, we cannot
exclude a negative role for DLX3WT/DLX3TDO heterodimers
in the control of DNp63a functions during development of
Fig. 5. DLX3WT/DLX3TDO heterodimers interacts with RAF1 and
promotes DNp63a protein degradation. A: Extracts from HaCaT
cells transiently transfected with an empty vector or a ﬁxed amount
(4mg) of DLX3WT,DLX3TDO, orDLX3WT/DLX3TDO (in a ratio of 1:1)
were immunoprecipitated (IP) with an anti-FLAG antibody and
analyzed byWBwith antibodies for FLAGandV5 tags. The input part
contains 5% of the material used in the IPs. B: HaCaT cells were
transiently transfected with an empty vector or increasing amounts
(as indicated) of DLX3WT, DLX3TDO, or DLX3WT/DLX3TDO
expression plasmids (in a 1:1 ratio). Total cell lysates were
immunoblotted with antibodies against p63, V5, pRAFS338, and
p21WAF1. Actin was used as loading control.
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other structures derived from epithelial–mesenchymal
interaction such as nails, hair, and tooth enamel.
In summary, our data highlight the importance of the p63-
DLX3 regulatory circuitry in the control of proliferation and
differentiation of epithelial cells. The p63-DLX3 molecular
pathway can be essential for the correct maturation and
stratiﬁcation of the adult epidermis as well as for the
morphogenesis of other structures requiring epithelial–
mesenchymal interaction, such as lip/palate closure and limb
bud growth/patterning. Remarkably, altered localization of
DLX3 gene expression is associated in retinoic acid-induced
forelimb ectrodactyly (Shimizu et al., 2007) and overlap
between p63 and DLX3 expression has been found in placenta
where major defects are observed in the DLX3/ embryos
(Morasso et al., 1999). Alterations of the p63-DLX3 molecular
pathway, either through misregulation of DLX3 gene
transcription or different sensitivity of DNp63a mutant
proteins to DLX3-mediated degradation, might result in p63
hyper or hypo-activity with pathological effects. For instance,
we have previously observed that EEC or SHFM-derived TA
and DNp63a proteins show a different activity on the DLX3
gene promoter compared to the corresponding wild-type
proteins (Radoja et al., 2007). It will be of clinical importance to
determine, in an in vivo model, how mutant p63 inﬂuences the
expression of DLX3 and ﬁnd out if it is correlated with different
p63-associated phenotypes.
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